The Clorox Company $CLX Position Lessened by Evermay Wealth Management LLC

Evermay Wealth Management LLC reduced its stake in shares of The Clorox Company (NYSE:CLX) by 12.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 695 shares of the company’s stock after selling 100 shares during the period. Evermay Wealth Management LLC’s holdings in Clorox were worth $83,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Stephens Inc. AR increased its holdings in shares of Clorox by 32.4% during the 2nd quarter. Stephens Inc. AR now owns 3,778 shares of the company’s stock valued at $454,000 after acquiring an additional 924 shares during the last quarter. Chicago Partners Investment Group LLC increased its holdings in shares of Clorox by 29.7% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 2,514 shares of the company’s stock valued at $330,000 after acquiring an additional 575 shares during the last quarter. MB Levis & Associates LLC increased its holdings in shares of Clorox by 3.3% during the 2nd quarter. MB Levis & Associates LLC now owns 6,095 shares of the company’s stock valued at $732,000 after acquiring an additional 194 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Clorox during the 2nd quarter valued at about $216,000. Finally, Chevy Chase Trust Holdings LLC increased its holdings in shares of Clorox by 0.9% during the 2nd quarter. Chevy Chase Trust Holdings LLC now owns 88,212 shares of the company’s stock valued at $10,592,000 after acquiring an additional 790 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Down 0.1%

Clorox stock opened at $119.60 on Tuesday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The business’s 50-day simple moving average is $121.56 and its 200-day simple moving average is $127.42. The firm has a market capitalization of $14.56 billion, a PE ratio of 18.34, a PEG ratio of 0.99 and a beta of 0.52. The Clorox Company has a 52 week low of $116.53 and a 52 week high of $171.37.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same period last year, the business earned $1.82 earnings per share. The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. Clorox’s dividend payout ratio (DPR) is 76.07%.

Analyst Ratings Changes

CLX has been the topic of a number of analyst reports. TD Cowen lowered their price objective on Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a report on Wednesday, October 1st. Barclays lowered their price objective on Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a report on Tuesday, September 30th. Citigroup lowered their price objective on Clorox from $135.00 to $130.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. BNP Paribas Exane lowered their price objective on Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a report on Friday. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $130.20.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.63% of the stock is currently owned by company insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.